Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 54% · prior close shown (market closed)
Limited proprietary earnings coverage for CTMX yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 33d ago
Reported figures for CytomX Therapeutics, Inc. — research only, not investment advice.
Updated
What happened recently for CytomX Therapeutics, Inc. (CTMX) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$3.35
Market cap
$729.96M
Profitable
No
Revenue $76.20M
Net income
$-17.37M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for CytomX Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow CytomX Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.